(c) 2024 PillSync.com

DR. RECKEWEG R65 Psoriasin Dailymed



Go PRO for all pill images

Otc - Active Ingredient Section


Active ingredients

Berberis aquifolium 4X 3 g, Hydrocotyle asiatica 4X 3 g, Arsenicum album 12X 1 g, Calcarea carbonica 30X 1 g, Graphites 12X 1 g, Natrum muriaticum 30X 1 g in 10 g.

Otc - Purpose Section


Purpose

Relieves symptoms associated with psoriasis

Indications & Usage Section


Uses

For the temporary relief of symptoms associated with psoriasis such as:
  • Cracked skin
  • Skin eruptions
  • Dry skin

Warnings Section


Warnings

OTC - STOP USE SECTION


Stop use and ask a doctor if symptoms persist, get worse, or if new symptoms occur.

OTC - PREGNANCY OR BREAST FEEDING SECTION


If pregnant or breastfeeding, ask a health care professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION


Keep out of reach of children.

Dosage & Administration Section


Directions Adults and children ≥ 12 years 5-10 drops 1-3 times daily in a little water or undiluted or as recommended.

Other Safety Information


Other information
  • Tamper resistant: do not use if safety ring at base of cap is broken.
  • Retain outer carton for full product information.



Inactive Ingredient Section


Inactive ingredients Ethanol, purified water.

Otc - Questions Section


Questions? Call 1-800-361-7872 or email questions@reckeweg.com

Package Label.principal Display Panel




NDC# 53346-1365-5 Dr. Reckeweg R65 Psoriasin Homeopathic preparation for the temporary relief of symptoms associated with psoriasis such as:
  • Cracked skin
  • Skin eruptions
  • Dry skin

Manufactured by: Dr. Reckeweg Co. GmbH D-64625 Bensheim Germany 1.68 fl oz(50 ml)

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site